Jean Van Rampelbergh is Doctor in Biomedical Sciences from the Université Libre de Bruxelles.
After a post-doctorate in Paris, he started a second one in 2000 in the pharma industry for Janssen Pharmaceutica Foundation, collaborating to early pre-clinical activities.
As of 2002, he shifted his activities towards the clinical part of the development. He started as a CRA for Organon and then moved to Sanofi-aventis in 2005 to successively embrace the functions of Project Leader, Clinical Operations Manager Head of the Clinical Study Unit of Sanofi in Belgium. During his last 2 years at Sanofi he was one of the five global responsible leaders for reshaping the clinical development pathway.
In 2013, he created his own consultancy company directed towards supporting spin-off and start-up companies for their clinical development needs at early stages. He recently successfully moved the biotech Imcyse into clinical stage in type 1 diabetes with excellent results in phase 1.
Next to this, Jean is eager to share his knowledge through training sessions for different audiences.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.